243 related articles for article (PubMed ID: 21937160)
1. Modeling ADAMTS13-von Willebrand factor interaction: Implications for oxidative stress-related cardiovascular diseases and type 2A von Willebrand disease.
Pozzi N; Lancellotti S; De Cristofaro R; De Filippis V
Biophys Chem; 2012 Jan; 160(1):1-11. PubMed ID: 21937160
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
Xiang Y; de Groot R; Crawley JT; Lane DA
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
[TBL] [Abstract][Full Text] [Related]
4. [Increased susceptibility of recombinant type 2A von Willebrand factor mutant A1500E to proteolysis by ADAMTS13].
Zhang JY; Su J; Ma ZN; Dong NZ; Wang YC; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):169-72. PubMed ID: 22781599
[TBL] [Abstract][Full Text] [Related]
5. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
Budde U; Schneppenheim R
Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
[TBL] [Abstract][Full Text] [Related]
6. The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.
de Groot R; Lane DA; Crawley JT
Blood; 2010 Oct; 116(16):3064-72. PubMed ID: 20647566
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
Chen J; Ling M; Fu X; López JA; Chung DW
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
[TBL] [Abstract][Full Text] [Related]
8. A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.
Zanardelli S; Chion AC; Groot E; Lenting PJ; McKinnon TA; Laffan MA; Tseng M; Lane DA
Blood; 2009 Sep; 114(13):2819-28. PubMed ID: 19587373
[TBL] [Abstract][Full Text] [Related]
9. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
[TBL] [Abstract][Full Text] [Related]
10. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
Kokame K
Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
[TBL] [Abstract][Full Text] [Related]
11. Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from ADAMTS-13.
Lancellotti S; De Filippis V; Pozzi N; Oggianu L; Rutella S; Scaglione GL; Maset F; Peyvandi F; Mannucci PM; De Cristofaro R
J Thromb Haemost; 2011 Aug; 9(8):1620-7. PubMed ID: 21605335
[TBL] [Abstract][Full Text] [Related]
12. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
[TBL] [Abstract][Full Text] [Related]
13. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
14. Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.
Jin SY; Skipwith CG; Zheng XL
Blood; 2010 Mar; 115(11):2300-10. PubMed ID: 20075158
[TBL] [Abstract][Full Text] [Related]
15. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.
Schneppenheim R; Michiels JJ; Obser T; Oyen F; Pieconka A; Schneppenheim S; Will K; Zieger B; Budde U
Blood; 2010 Jun; 115(23):4894-901. PubMed ID: 20351307
[TBL] [Abstract][Full Text] [Related]
16. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
[TBL] [Abstract][Full Text] [Related]
17. Shear stress and von Willebrand factor in health and disease.
Tsai HM
Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
[TBL] [Abstract][Full Text] [Related]
18. Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.
Hassenpflug WA; Budde U; Obser T; Angerhaus D; Drewke E; Schneppenheim S; Schneppenheim R
Blood; 2006 Mar; 107(6):2339-45. PubMed ID: 16322474
[TBL] [Abstract][Full Text] [Related]
19. Unwinding the von Willebrand factor strings puzzle.
De Ceunynck K; De Meyer SF; Vanhoorelbeke K
Blood; 2013 Jan; 121(2):270-7. PubMed ID: 23093621
[TBL] [Abstract][Full Text] [Related]
20. The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.
Ling J; Su J; Ma Z; Ruan C
Thromb Res; 2013 Jun; 131(6):529-34. PubMed ID: 23683325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
